Anne-Marie C Dingemans

Anne-Marie C Dingemans

UNVERIFIED PROFILE

Are you Anne-Marie C Dingemans?   Register this Author

Register author
Anne-Marie C Dingemans

Anne-Marie C Dingemans

Publications by authors named "Anne-Marie C Dingemans"

Are you Anne-Marie C Dingemans?   Register this Author

100Publications

2443Reads

25Profile Views

Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey.

Lung Cancer 2019 Oct 13;136:145-147. Epub 2019 Aug 13.

The University of Manchester, Division of Cancer Sciences, The Christie NHS Foundation Trust, Manchester, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.08.007DOI Listing
October 2019

Survival of patients with non-small cell lung cancer having leptomeningeal metastases treated with immune checkpoint inhibitors.

Eur J Cancer 2019 Jul 13;116:182-189. Epub 2019 Jun 13.

Department of Medical Oncology, Gustave Roussy Cancer Campus, Institut d'Oncologie Thoracique (IOT), Gustave Roussy, Université Paris-Saclay, F-94805, Villejuif, France; Paris-Sud University, Orsay, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2019.05.019DOI Listing
July 2019

Individualized accelerated isotoxic concurrent chemo-radiotherapy for stage III non-small cell lung cancer: 5-Year results of a prospective study.

Radiother Oncol 2019 Jun 27;135:141-146. Epub 2019 Mar 27.

Maastricht University Medical Center, Department of Pulmonology, GROW School for Oncology and Developmental Biology, Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2019.03.009DOI Listing
June 2019

Defining Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Systematic Review.

J Thorac Oncol 2019 Jun 11. Epub 2019 Jun 11.

Department of Intensive Care and Oncological Emergencies and Thoracic Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.05.037DOI Listing
June 2019

Cross-sectional and longitudinal assessment of muscle from regular chest computed tomography scans: L1 and pectoralis muscle compared to L3 as reference in non-small cell lung cancer.

Int J Chron Obstruct Pulmon Dis 2019 3;14:781-789. Epub 2019 Apr 3.

Department of Respiratory Medicine, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre, Maastricht, the Netherlands,

View Article

Download full-text PDF

Source
https://www.dovepress.com/cross-sectional-and-longitudinal-a
Publisher Site
http://dx.doi.org/10.2147/COPD.S194003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452800PMC
April 2019

Is it time to incorporate surgery in the treatment of stage IV non-small cell lung cancer?

Lung Cancer 2019 03 30;129:95-97. Epub 2019 Jan 30.

Dept. of Pulmonary Diseases, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center+, PO Box 5800, 6202 AZ, Maastricht, the Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.01.011DOI Listing
March 2019

Is Concurrent Chemoradiotherapy Also the Best Treatment for Elderly Patients with Limited-Stage Small Cell Lung Cancer? - What the CONVERT Data Can Tell Us.

J Thorac Oncol 2019 Jan;14(1):13-15

Department of Pulmonary Diseases, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.11.005DOI Listing
January 2019

Progression-Free Survival and Overall Survival Beyond 5 Years of NSCLC Patients With Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450).

J Thorac Oncol 2018 12 22;13(12):1958-1961. Epub 2018 Sep 22.

Department of Pulmonology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864183093
Publisher Site
http://dx.doi.org/10.1016/j.jtho.2018.07.098DOI Listing
December 2018

Study Protocol of the NVALT25-ELDAPT Trial: Selecting the Optimal Treatment for Older Patients With Stage III Non-small-cell Lung Cancer.

Clin Lung Cancer 2018 11 9;19(6):e849-e852. Epub 2018 Jul 9.

MAASTRO Clinic, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2018.07.003DOI Listing
November 2018

Editorial: Central Nervous System Metastases in Lung Cancer Patients: From Prevention to Diagnosis and Treatment.

Front Oncol 2018 6;8:511. Epub 2018 Nov 6.

Department of Pulmonary Diseases, GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2018.00511DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232302PMC
November 2018

Applicability of a prognostic CT-based radiomic signature model trained on stage I-III non-small cell lung cancer in stage IV non-small cell lung cancer.

Lung Cancer 2018 10 20;124:6-11. Epub 2018 Jul 20.

The D-Lab: Decision Support for Precision Medicine, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center+, Universiteitssingel 40, 6229 ER, Maastricht, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.07.023DOI Listing
October 2018

What you see is (not) what you get: tools for a non-radiologist to evaluate image quality in lung cancer.

Lung Cancer 2018 09 18;123:112-115. Epub 2018 Jul 18.

Department of Pulmonary Diseases, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center+, P. Debyelaan 25, 6229 HX, Maastricht, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.07.014DOI Listing
September 2018

Geriatric Assessment for Older Patients with Non-small Cell Lung Cancer: Daily Practice of Centers Participating in the NVALT25-ELDAPT Trial.

Lung 2018 08 12;196(4):463-468. Epub 2018 Apr 12.

Department of Clinical Epidemiology, VieCuri Medical Center, P.O. box 1926, 5900 BX, Venlo, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00408-018-0116-8DOI Listing
August 2018

Prophylactic Cranial Irradiation Versus Observation in Radically Treated Stage III Non-Small-Cell Lung Cancer: A Randomized Phase III NVALT-11/DLCRG-02 Study.

J Clin Oncol 2018 08 22;36(23):2366-2377. Epub 2018 May 22.

Dirk De Ruysscher and Anne-Marie C. Dingemans, Maastricht University Medical Center; GROW Research Institute, Maastricht; John Praag, Erasmus University Medical Center, Rotterdam; Jose Belderbos, Egbert Smit, Harm van Tinteren, and Vincent van der Noort, Netherlands Cancer Institute; Frank Lagerwaard, Free University Medical Center, Amsterdam; Caroline Tissing-Tan, Radiotherapy Institute Arnhem, Arnhem; Judith Herder, Antonius Hospital Nieuwegein, Nieuwegein; Tjeerd Haitjema, Medical Center Alkmaar, Alkmaar; Fred Ubbels and Harry J.M. Groen, University of Groningen; University Medical Center Groningen, Groningen; Sherif Y. El Sharouni, University Medical Center Utrecht, Utrecht; Jos A. Stigt, Isala Hospital, Zwolle, The Netherlands; and Dirk De Ruysscher, KU Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.77.5817DOI Listing
August 2018

The Prevention of Brain Metastases in Non-Small Cell Lung Cancer by Prophylactic Cranial Irradiation.

Front Oncol 2018 26;8:241. Epub 2018 Jul 26.

Department of Radiation Oncology (Maastro Clinic), Maastricht University Medical Centre, GROW School of Oncology and Developmental Biology, Maastricht, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2018.00241DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070634PMC
July 2018

Brain imaging in early stage non-small cell lung cancer: still a controversial topic?

J Thorac Dis 2018 Jul;10(Suppl 18):S2168-S2171

Department of Pulmonary Diseases, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
http://jtd.amegroups.com/article/view/22352/17266
Publisher Site
http://dx.doi.org/10.21037/jtd.2018.06.68DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072952PMC
July 2018

New Insights into the Molecular Characteristics of Pulmonary Carcinoids and Large Cell Neuroendocrine Carcinomas, and the Impact on Their Clinical Management.

J Thorac Oncol 2018 06 14;13(6):752-766. Epub 2018 Feb 14.

Genetic Cancer Susceptibility Group, International Agency for Research on Cancer, IARC-WHO, Lyon, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.02.002DOI Listing
June 2018

A phase I study of nintedanib combined with cisplatin/gemcitabine as first-line therapy for advanced squamous non-small cell lung cancer (LUME-Lung 3).

Lung Cancer 2018 06 9;120:27-33. Epub 2018 Mar 9.

Department of Oncology, University College London Cancer Institute, London, UK; University College London Hospitals NHS Foundation Trust, London, UK. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01695002183029
Publisher Site
http://dx.doi.org/10.1016/j.lungcan.2018.03.007DOI Listing
June 2018

Invasive Aspergillosis Mimicking Metastatic Lung Cancer.

Front Oncol 2018 5;8:188. Epub 2018 Jun 5.

Department of Respiratory Medicine, Maastricht University Medical Centre (MUMC+), Maastricht, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2018.00188DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996088PMC
June 2018

Exploration of the platelet proteome in patients with early-stage cancer.

J Proteomics 2018 04 10;177:65-74. Epub 2018 Feb 10.

OncoProteomics Laboratory, Department of Medical Oncology, Cancer Center Amsterdam, VU Medical Center, Amsterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jprot.2018.02.011DOI Listing
April 2018

Current perspective: Osimertinib-induced QT prolongation: new drugs with new side-effects need careful patient monitoring.

Eur J Cancer 2018 03;91:92-98

Dept. of Pulmonary Diseases, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center+, PO Box 5800, 6202 AZ, Maastricht, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09598049173149
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2017.12.011DOI Listing
March 2018

Patterns of treatment and survival among older patients with stage III non-small cell lung cancer.

Lung Cancer 2018 02 20;116:55-61. Epub 2017 Dec 20.

Department of Clinical Epidemiology, VieCuri Medical Centre, Venlo, The Netherlands; Department of Epidemiology, Maastricht University Medical Centre+, GROW School for Oncology and Developmental Biology, Maastricht, the Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.12.013DOI Listing
February 2018

Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome.

Clin Cancer Res 2018 01 24;24(1):33-42. Epub 2017 Oct 24.

Department of Pulmonary Diseases, GROW School for Oncology & Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-1921DOI Listing
January 2018

Quality assessment of positron emission tomography scans: recommendations for future multicentre trials.

Acta Oncol 2017 Nov 22;56(11):1459-1464. Epub 2017 Aug 22.

g Department of Pulmonology, GROW-School for Oncology and Developmental Biology , Maastricht University Medical Centre , Maastricht , Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/0284186X.2017.1346824DOI Listing
November 2017

Why we should improve current practice of diagnosing and treating pulmonary large cell neuroendocrine carcinomas in patients with advanced disease.

Eur Respir J 2017 10 26;50(4). Epub 2017 Oct 26.

Dept of Pulmonary Diseases, GROW school for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.01658-2017DOI Listing
October 2017

A combination of platelet features allows detection of early-stage cancer.

Eur J Cancer 2017 07 17;80:5-13. Epub 2017 May 17.

Department of Physiology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Center+, Maastricht, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.04.010DOI Listing
July 2017

Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?

Eur Respir J 2017 06 1;49(6). Epub 2017 Jun 1.

Dept of Pulmonary Diseases, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.01838-2016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898951PMC
June 2017

Heat shock protein antagonists in early stage clinical trials for NSCLC.

Expert Opin Investig Drugs 2017 May 8;26(5):541-550. Epub 2017 Mar 8.

a Department of Pulmonary Diseases, GROW - School for oncology and developmental biology , Maastricht University Medical Center+ , Maastricht , The Netherlands.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/13543784.2017.1
Publisher Site
http://dx.doi.org/10.1080/13543784.2017.1302428DOI Listing
May 2017

Management of stage I and II nonsmall cell lung cancer.

Eur Respir J 2017 01 3;49(1). Epub 2017 Jan 3.

Dept of Thoracic and Vascular Surgery, Antwerp University Hospital, Antwerp, Belgium

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.00764-2016DOI Listing
January 2017

Differentiating head and neck carcinoma from lung carcinoma with an electronic nose: a proof of concept study.

Eur Arch Otorhinolaryngol 2016 Nov 16;273(11):3897-3903. Epub 2016 Apr 16.

Department of Otorhinolaryngology, Head and Neck Surgery, Maastricht University Medical Center, PO Box 5800, 6202 AZ, Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00405-016-4038-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052311PMC
November 2016

Development of symptomatic brain metastases after chemoradiotherapy for stage III non-small cell lung cancer: Does the type of chemotherapy regimen matter?

Lung Cancer 2016 11 9;101:68-75. Epub 2016 Sep 9.

Dept. of Pulmonary Diseases, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center+, PO Box 5800, 6202 AZ Maastricht, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2016.09.008DOI Listing
November 2016

Is selective nodal irradiation in non-small cell lung cancer still safe when using IMRT? Results of a prospective cohort study.

Radiother Oncol 2016 11 21;121(2):322-327. Epub 2016 Nov 21.

Department of Radiation Oncology (MAASTRO clinic), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2016.10.001DOI Listing
November 2016

Stage III Non-Small Cell Lung Cancer in the elderly: Patient characteristics predictive for tolerance and survival of chemoradiation in daily clinical practice.

Radiother Oncol 2016 10 10;121(1):26-31. Epub 2016 Aug 10.

Department of Clinical Epidemiology, VieCuri Medical Centre, Venlo, The Netherlands; Department of Epidemiology, Maastricht University Medical Centre, GROW School for Oncology and Developmental Biology, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2016.07.025DOI Listing
October 2016

Do associated auto-antibodies influence the outcome of myasthenia gravis after thymectomy?

Autoimmunity 2015 30;48(8):552-5. Epub 2015 Jul 30.

i Department of Neuroscience , Maastricht University Medical Centre , Maastricht , The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/08916934.2015.1064400DOI Listing
September 2016

Selective mediastinal node irradiation in non-small cell lung cancer in the IMRT/VMAT era: How to use E(B)US-NA information in addition to PET-CT for delineation?

Radiother Oncol 2016 08 10;120(2):273-8. Epub 2016 Jun 10.

Radiation Oncology, University Hospitals Leuven/KU Leuven, Belgium; Radiation Oncology (MAASTRO Clinic), GROW, Maastricht University Medical Center, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2016.05.023DOI Listing
August 2016

Early Weight Loss during Chemoradiotherapy Has a Detrimental Impact on Outcome in NSCLC.

J Thorac Oncol 2016 06 3;11(6):873-9. Epub 2016 Mar 3.

Department of Respiratory Medicine, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.02.013DOI Listing
June 2016

A Population-Based Analysis of Application of WHO Nomenclature in Pathology Reports of Pulmonary Neuroendocrine Tumors.

J Thorac Oncol 2016 Apr 9;11(4):593-602. Epub 2016 Jan 9.

Department of Pulmonary Diseases, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2015.12.106DOI Listing
April 2016

Neuroendocrine Cancer of the Lung: A Diagnostic Puzzle.

J Thorac Oncol 2016 Mar 24;11(3):e35-8. Epub 2015 Dec 24.

Department of Respiratory Medicine, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2015.10.013DOI Listing
March 2016

Inter-reader reproducibility of dynamic contrast-enhanced magnetic resonance imaging in patients with non-small cell lung cancer treated with bevacizumab and erlotinib.

Lung Cancer 2016 Mar 30;93:20-7. Epub 2015 Dec 30.

Department of Radiology, Maastricht University Medical Center, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.12.009DOI Listing
March 2016

Proposals for the M-descriptors of the Eight TNM Classification for Non-Small Cell Lung Cancer: Are More Data Needed?

J Thorac Oncol 2016 Mar;11(3):e42-3

Department of Radiation Oncology (MAASTRO clinic), GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands; Department of Oncology, Experimental Radiation Oncology, Katholieke Universiteit, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2015.11.013DOI Listing
March 2016

Multiparametric imaging of patient and tumour heterogeneity in non-small-cell lung cancer: quantification of tumour hypoxia, metabolism and perfusion.

Eur J Nucl Med Mol Imaging 2016 Feb 4;43(2):240-248. Epub 2015 Sep 4.

Department of Radiation Oncology (MAASTRO), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-015-3169-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700090PMC
February 2016

Clinical features of large cell neuroendocrine carcinoma: a population-based overview.

Eur Respir J 2016 Feb 5;47(2):615-24. Epub 2015 Nov 5.

Dept of Pulmonary Diseases, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.00618-2015DOI Listing
February 2016

Effect of Bisphosphonates, Denosumab, and Radioisotopes on Bone Pain and Quality of Life in Patients with Non-Small Cell Lung Cancer and Bone Metastases: A Systematic Review.

J Thorac Oncol 2016 Feb 22;11(2):155-73. Epub 2015 Dec 22.

Department of Pulmonary Diseases, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2015.10.001DOI Listing
February 2016

An Unmet Need in the WHO 2015 Biopsy Classification: Poorly Differentiated NSCCs with Positive Neuroendocrine Markers.

J Thorac Oncol 2016 Feb;11(2):e25-6

Department of Respiratory Disease, Maastricht University Medical Centre, Maastricht, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2015.10.017DOI Listing
February 2016

CT-Guided Percutaneous Transthoracic Needle Biopsies Using 10G Large-Core Needles: Initial Experience.

Cardiovasc Intervent Radiol 2015 Dec 13;38(6):1603-10. Epub 2015 May 13.

Department of Radiology, Maastricht University Medical Center, P. Debyelaan 25, PO Box 5800, 6202 AZ, Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s00270-015-1098
Web Search
http://link.springer.com/10.1007/s00270-015-1098-z
Publisher Site
http://dx.doi.org/10.1007/s00270-015-1098-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648960PMC
December 2015

An Uncommon Presentation of Brain Metastases in a Lung Cancer Patient.

J Thorac Oncol 2015 Nov;10(11):1655-6

*Department of Pulmonary Diseases, †Department of Radiology, Maastricht University Medical Center+, Maastricht, The Netherlands; ‡Department of Pathology, University Hospital Antwerpen, Antwerpen, Belgium; §Department of Neurology, Maastricht University Medical Center+, Maastricht, The Netherlands; and ‖Department of Thoracic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000602DOI Listing
November 2015

Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis.

Lung Cancer 2015 Sep 6;89(3):255-61. Epub 2015 Jun 6.

Department of Pulmonary Diseases, VU University Medical Center, Boelelaan 1117, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands; Department of Pulmonary Diseases, The Netherlands Cancer Institute, P.O. Box 90203, 1006 BE Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.05.023DOI Listing
September 2015

Robotic thymectomy in patients with myasthenia gravis: neurological and surgical outcomes.

Eur J Cardiothorac Surg 2015 Jul 18;48(1):40-5. Epub 2014 Sep 18.

Department of Cardiothoracic Surgery, Maastricht University Medical Centre, Maastricht, Netherlands CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, Netherlands

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ejcts/ezu352DOI Listing
July 2015

Safety of cranial radiotherapy concurrent with tyrosine kinase inhibitors in non-small cell lung cancer patients: A systematic review.

Cancer Treat Rev 2015 Jul 13;41(7):634-45. Epub 2015 May 13.

Dept. of Pulmonary Diseases, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center+, PO Box 5800, 6202 AZ Maastricht, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2015.05.005DOI Listing
July 2015

Galectin expression profiling identifies galectin-1 and Galectin-9Δ5 as prognostic factors in stage I/II non-small cell lung cancer.

PLoS One 2014 26;9(9):e107988. Epub 2014 Sep 26.

Angiogenesis Laboratory, Department of Medical Oncology, VU University medical center, Amsterdam, The Netherlands; Department of Radiotherapy, VU University medical center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0107988PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178059PMC
June 2015

Preserved muscle oxidative metabolic phenotype in newly diagnosed non-small cell lung cancer cachexia.

J Cachexia Sarcopenia Muscle 2015 Jun 15;6(2):164-73. Epub 2015 Apr 15.

Department of Respiratory Medicine, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre +, Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcsm.12007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458082PMC
June 2015

Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort.

J Clin Oncol 2015 Mar 9;33(9):992-9. Epub 2015 Feb 9.

Julien Mazières, Damien Rouvière, and Julie D. Milia, Hôpital Larrey, Centre Hospitalier Universitaire, Université Paul Sabatier; Thomas Filleron, Institut Universitaire du Cancer, Toulouse; Gérard Zalcman, Centre Hospitalier Universitaire, Université de Caen-Basse Normandie, Caen; Pamela Biondani and Benjamin Besse, Gustave Roussy, Villejuif; Fabrice Barlesi, Aix-Marseille University, Assistance Publique Hôpitaux de Marseille, Marseille; Hervé Léna, Centre Hospitalier Universitaire, Rennes; Isabelle Monnet, Centre Hospitalier Intercommunal de Créteil, Créteil; Luc Thiberville, Centre Hospitalier Universitaire, Rouen; Nicolas Pecuchet, Institut Curie, Paris, France; Lucio Crinò, Medica-Azienda Ospedaliera, Perugia; Federico Cappuzzo, Istituto Toscano Tumori, Ospedale Civile, Livorno, Italy; Anne-Marie C. Dingemans, Maastricht University Medical Center, Maastricht; Egbert F. Smit, VU University Medical Center, Amsterdam, the Netherlands; Sacha I. Rothschild, University Hospital Basel, Medical Oncology, Basel; Christian Spirig, Klinik St Anna; Joachim Diebold and Oliver Gautschi, Cantonal Hospital Luzern, Lucerne, Switzerland; Rafal Dziadziuszko, Gdansk Medical University, Gdansk, Poland; Jurgen Wolf and Roman K. Thomas, Center of Integrated Oncology Köln-Bonn, University Hospital Cologne, University of Cologne; Frauke Leenders and Roman K. Thomas, University of Cologne; Johannes M. Heuckmann, Blackfield AG, Cologne, Germany.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/02/03/JCO.2014.58
Web Search
http://jco.ascopubs.org/content/early/2015/02/03/JCO.2014.58
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.58.3302
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.58.3302DOI Listing
March 2015

Difference in outcome between types of KRAS mutation may point toward difference in tumor biology.

J Thorac Oncol 2015 Feb;10(2):e9

Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands Department of Pulmonary Diseases, Maastricht University Medical Center, Maastricht, The Netherlands Department of Epidemiology and, Biostatistics, VU University Medical Center, Amsterdam, The Netherlands Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000431DOI Listing
February 2015

Phase II drugs that are currently in development for the treatment of cachexia.

Expert Opin Investig Drugs 2014 Dec 24;23(12):1655-69. Epub 2014 Jul 24.

Maastricht University Medical Center, Department of Respiratory Medicine , PO Box 5800, 6202 AZ Maastricht , The Netherlands +31 43 3871318 ; +31 43 3875051 ; a.dingemans

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.2014.942729DOI Listing
December 2014

Interobserver variability for the WHO classification of pulmonary carcinoids.

Am J Surg Pathol 2014 Oct;38(10):1429-36

Departments of *Molecular Cell Biology #Pulmonology ∥∥Pathology, GROW - School for Oncology & Developmental Biology, Maastricht University Medical Center, Maastricht **Department of Surgery, Máxima Medical Center, Veldhoven, The Netherlands; CARIM - School for Cardiovascular Diseases, Maastricht University Medical Center, Maastricht, The Netherlands †Departments of Pathology, Jeroen Bosch Hospital, 's-Hertogenbosch ‡Maasstad Hospital, Rotterdam §Sint Antonius Hospital, Nieuwegein ∥VU University Medical Center, Amsterdam ††Departments of Pulmonology, Atrium Medical Center, Heerlen ‡‡Viecuri Medical Center, Venlo §§Catharina Hospital, Eindhoven, The Netherlands ¶Department of Oncology, Division of Pathology, University of Turin at San Luigi Hospital, Orbassano, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000300DOI Listing
October 2014

Patient selection for whole brain radiotherapy (WBRT) in a large lung cancer cohort: Impact of a new Dutch guideline on brain metastases.

Acta Oncol 2014 Jul 23;53(7):945-51. Epub 2014 Apr 23.

Department of Pulmonary Diseases, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center , Maastricht , The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/0284186X.2014.906746DOI Listing
July 2014

Early body weight loss during concurrent chemo-radiotherapy for non-small cell lung cancer.

J Cachexia Sarcopenia Muscle 2014 Jun 23;5(2):127-37. Epub 2014 Jan 23.

Department of Respiratory Medicine, NUTRIM School for Nutrition, Toxicology & Metabolism, Maastricht University Medical Centre+, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13539-013-0127-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053563PMC
June 2014

A phase I study of concurrent individualized, isotoxic accelerated radiotherapy and cisplatin-vinorelbine-cetuximab in patients with stage III non-small-cell lung cancer.

J Thorac Oncol 2014 May;9(5):710-6

*Department of Pulmonology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands; †Department of Pulmonology, Atrium Medical Centre, Heerlen, The Netherlands; ‡Department of Radiation Oncology (MAASTRO Clinic), GROW School for Oncology and Developmental Biology; §Department of Nuclear Medicine, and ‖Department of Radiology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands; and ¶Department of Radiation Oncology, University Hospitals Leuven/KU Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153028
Publisher Site
http://dx.doi.org/10.1097/JTO.0000000000000151DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132032PMC
May 2014

What to choose as radical local treatment for lung metastases from colo-rectal cancer: surgery or radiofrequency ablation?

Cancer Treat Rev 2014 Feb 13;40(1):60-7. Epub 2013 Jun 13.

Maastricht University, Faculty of Health, Medicine and Life Sciences, School of Medicine, Maastricht, The Netherlands; Department of Radiation Oncology (MAASTRO), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2013.05.004DOI Listing
February 2014

Arginase-1 mRNA expression correlates with myeloid-derived suppressor cell levels in peripheral blood of NSCLC patients.

Lung Cancer 2013 Sep 11;81(3):468-474. Epub 2013 Jul 11.

Department of Pulmonary Medicine, Erasmus Medical University Center, Rotterdam, The Netherlands; Department of Pulmonary Medicine, Amphia Hospital Breda, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2013.06.005DOI Listing
September 2013

Nuclear transcription factor κ B activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia.

Am J Clin Nutr 2013 Sep 31;98(3):738-48. Epub 2013 Jul 31.

Department of Respiratory Medicine, NUTRIM School for Nutrition, Toxicology and Metabolism, Maastricht University Medical Centre, Maastricht, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3945/ajcn.113.058388DOI Listing
September 2013

Total gross tumor volume is an independent prognostic factor in patients treated with selective nodal irradiation for stage I to III small cell lung cancer.

Int J Radiat Oncol Biol Phys 2013 Apr 29;85(5):1319-24. Epub 2012 Nov 29.

Department of Radiation Oncology (MAASTRO clinic), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2012.10.003DOI Listing
April 2013

A phase II study of sorafenib in patients with platinum-pretreated, advanced (Stage IIIb or IV) non-small cell lung cancer with a KRAS mutation.

Clin Cancer Res 2013 Feb 6;19(3):743-51. Epub 2012 Dec 6.

Department of Pulmonary Diseases and GROW- School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-1779DOI Listing
February 2013

Mature results of a phase II trial on individualised accelerated radiotherapy based on normal tissue constraints in concurrent chemo-radiation for stage III non-small cell lung cancer.

Eur J Cancer 2012 Oct 18;48(15):2339-46. Epub 2012 May 18.

Department of Radiation Oncology (MAASTRO Clinic), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2012.04.014DOI Listing
October 2012

Response assessment using 18F-FDG PET early in the course of radiotherapy correlates with survival in advanced-stage non-small cell lung cancer.

J Nucl Med 2012 Oct 9;53(10):1514-20. Epub 2012 Aug 9.

Department of Radiation Oncology (MAASTRO), GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.111.102566DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4667805PMC
October 2012

Treatment with curative intent of stage III non-small cell lung cancer patients of 75 years: a prospective population-based study.

Eur J Cancer 2011 Dec 4;47(18):2691-7. Epub 2011 Jul 4.

Department of Radiation Oncology, MAASTRO Clinic, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2011.06.023DOI Listing
December 2011

MicroRNA expression and clinical outcome of small cell lung cancer.

PLoS One 2011 22;6(6):e21300. Epub 2011 Jun 22.

Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0021300PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120860PMC
November 2011

Low molecular weight heparins in the treatment of lung cancer.

Expert Opin Investig Drugs 2011 Nov 7;20(11):1517-22. Epub 2011 Oct 7.

VU Medical Center, Pulmonology, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.2011.625008DOI Listing
November 2011